No Result
View All Result
  • Login
Thursday, August 6, 2026
theadvisertimes.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
theadvisertimes.com
No Result
View All Result
Home Money

Doctors Are Quietly Phasing Out These 6 Medications for Seniors—But Millions Still Take Them Daily

by theadvisertimes.com
4 months ago
in Money
Reading Time: 4 mins read
A A
0
Doctors Are Quietly Phasing Out These 6 Medications for Seniors—But Millions Still Take Them Daily
Share on FacebookShare on TwitterShare on LInkedIn


Image Source: Shutterstock

If you or a loved one takes daily prescriptions, this could be one of the most important reads of the year. Doctors aren’t always loudly announcing it, but many commonly used medications for seniors are being reconsidered due to growing safety concerns. Guidelines like the American Geriatrics Society Beers Criteria are increasingly influencing what doctors prescribe—and what they avoid. Here are six medications for seniors that doctors are slowly phasing out, and what you need to know if you’re taking any of them.

1. Benzodiazepines (Common Anxiety and Sleep Medications)

Benzodiazepines like Xanax, Valium, and Ativan are still widely prescribed for anxiety and insomnia. However, these medications for seniors are now strongly discouraged in many cases. They can cause drowsiness, confusion, and significantly increase the risk of falls and fractures. Older adults process these drugs more slowly, which means effects linger longer and build up in the body. Long-term use has also been linked to cognitive decline and even dementia risk in some studies.

2. Anticholinergic Drugs (Allergy and Bladder Medications)

Anticholinergic medications are found in many over-the-counter and prescription drugs, including allergy pills and bladder control medications. These medications for seniors can interfere with brain function and are known to cause confusion, blurred vision, and dizziness. They also increase the risk of falls and may contribute to long-term cognitive decline. Some research suggests a strong link between long-term use and dementia risk. Despite this, many seniors still take common versions like diphenhydramine (Benadryl) regularly.

3. “Z-Drugs” Sleep Aids (Ambien, Lunesta)

Sleep medications like Ambien and Lunesta are often seen as safer alternatives to older sedatives. However, doctors are increasingly grouping them with high-risk medications for seniors. These drugs can cause confusion, balance issues, and next-day grogginess that increases fall risk. Research shows they offer only minimal improvements in sleep quality for older adults. At the same time, they carry similar risks to benzodiazepines, including hospitalizations and accidents. Because of this, many providers are shifting toward non-drug sleep strategies.

4. Muscle Relaxants (Often Prescribed for Pain)

Muscle relaxants like cyclobenzaprine and carisoprodol are frequently prescribed for back or joint pain. But these medications for seniors are now considered risky due to their sedative effects. They can cause confusion, dizziness, and even heart-related side effects in older adults. The biggest concern is the increased likelihood of falls and injuries. In many cases, safer alternatives like physical therapy or targeted pain management are recommended instead.

5. Certain Diabetes Drugs (Like Glyburide)

Some older diabetes medications, particularly glyburide, are being phased out for seniors. These medications for seniors can cause dangerously low blood sugar episodes, which may lead to fainting or hospitalization. Older adults are especially vulnerable because their bodies regulate glucose differently. Newer medications offer more stable blood sugar control with fewer risks. Doctors now often recommend switching to safer alternatives when possible.

6. Long-Term NSAIDs (Common Pain Relievers)

Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen are commonly used for chronic pain. However, long-term use of these medications for seniors can increase the risk of stomach bleeding, kidney damage, and heart problems. These risks are significantly higher in people over 75 or those taking other medications. Even over-the-counter use can become dangerous when taken regularly. Many doctors now recommend limiting use or exploring safer pain management options.

What Seniors Should Do Before Stopping Any Medication

Hearing that a medication may be risky can feel alarming, but stopping suddenly can be dangerous. Many medications for seniors require careful tapering or replacement with safer alternatives.

The best step is to schedule a medication review with your doctor or pharmacist. Bring a complete list of prescriptions, over-the-counter drugs, and supplements. Ask whether each medication is still necessary and if safer options exist. This process, often called “deprescribing,” is becoming more common in senior care.

Why These Changes Matter More Than Ever

As the population ages, more seniors are taking multiple medications at once, increasing the risk of harmful interactions. Studies show that older adults are more likely to experience severe side effects and complications from medications. In fact, many adverse drug events in seniors are considered preventable. That’s why guidelines continue to evolve and why doctors are quietly adjusting their prescribing habits. Staying informed can help you or your loved ones avoid unnecessary risks. The goal isn’t to scare—but to empower smarter, safer health decisions.

Have you or a loved one been prescribed any of these medications for seniors, and were you aware of the risks? Share your experience in the comments.

What to Read Next

7 Over-the-Counter Medications Seniors Should Think Twice About Taking Every Day

The ER Risk No One Talks About: 6 Everyday Medications Doctors Need to Know You Take

8 Everyday Medications That Experts Warn Seniors Should Double-Check

Medicare’s New Drug Price Reductions Start Soon: Here Are the 10 Medications Affected

7 Common Medications Linked to Long-Term Cognitive Decline



Source link

Tags: DailyDoctorsMedicationsmillionsPhasingQuietlySeniorsBut
ShareTweetShare
Previous Post

Google, Banks to Back $5B Anthropic Data Center in Texas: Report

Next Post

‘Airport Dad’ faces reckoning amid long lines as travelers told not to arrive too early

Related Posts

6-Figure Trade Jobs. Surely Not? Nvidia CEO Says ‘The Skilled Craft Segment of Every Economy Is Going to See a Boom’

6-Figure Trade Jobs. Surely Not? Nvidia CEO Says ‘The Skilled Craft Segment of Every Economy Is Going to See a Boom’

by theadvisertimes.com
August 6, 2026
0

In January 2026, Nvidia CEO Jensen Huang stood on a stage in Davos and told a room full of the...

4 Grocery Assistance Programs Seniors Should Check Before Summer Ends

4 Grocery Assistance Programs Seniors Should Check Before Summer Ends

by theadvisertimes.com
August 5, 2026
0

Grocery prices continue to challenge retirement budgets, and many older adults are spending far more on food than they expected...

6 RMD Mistakes That Could Cost Retirees Money Before Year-End

6 RMD Mistakes That Could Cost Retirees Money Before Year-End

by theadvisertimes.com
August 5, 2026
0

If you’re a retiree, you likely know about (and are hopefully very familiar with) Required Minimum Distributions (RMDs). The IRS...

Adults Over 50: Ask These Vaccine Questions Before Cold and Flu Season

Adults Over 50: Ask These Vaccine Questions Before Cold and Flu Season

by theadvisertimes.com
August 5, 2026
0

Every fall, many adults over 50 schedule annual checkups, refill prescriptions, and prepare for flu season. It’s also one of...

Don’t Trust the Caller ID: How to Spot Medicare and Social Security Scam Calls

Don’t Trust the Caller ID: How to Spot Medicare and Social Security Scam Calls

by theadvisertimes.com
August 4, 2026
0

Your phone rings, and the caller ID says “Social Security Administration.” The person on the other end sounds professional, knows...

6 Retirement Tax Breaks Many Older Americans Miss Each Year

6 Retirement Tax Breaks Many Older Americans Miss Each Year

by theadvisertimes.com
August 4, 2026
0

Many retirees assume their tax bill automatically shrinks after they stop working. In reality, retirement comes with its own complicated...

Next Post
‘Airport Dad’ faces reckoning amid long lines as travelers told not to arrive too early

'Airport Dad' faces reckoning amid long lines as travelers told not to arrive too early

Psychology says people who compulsively tidy and reorganize aren’t control freaks – they learned early that the one thing they could control was the physical space around them

Psychology says people who compulsively tidy and reorganize aren't control freaks - they learned early that the one thing they could control was the physical space around them

  • Trending
  • Comments
  • Latest
SEC pushes private market access, but retail is already in

SEC pushes private market access, but retail is already in

July 16, 2026
How I Maximize My Sapphire Reserve Dining Credit

How I Maximize My Sapphire Reserve Dining Credit

July 10, 2026
The Weekly Notable Startup Funding Report: 6/22/26 – AlleyWatch

The Weekly Notable Startup Funding Report: 6/22/26 – AlleyWatch

June 21, 2026
The 10 Largest NYC Tech Startup Funding Rounds of June 2026 – AlleyWatch

The 10 Largest NYC Tech Startup Funding Rounds of June 2026 – AlleyWatch

July 6, 2026
The Weekly Notable Startup Funding Report: 7/20/26 – AlleyWatch

The Weekly Notable Startup Funding Report: 7/20/26 – AlleyWatch

July 20, 2026
The Hidden Cost of Chaos: Challenges with Spreadsheet-Based Channel Management in 2026

The Hidden Cost of Chaos: Challenges with Spreadsheet-Based Channel Management in 2026

May 6, 2026
Britannia Q1 Results: Profit rises 14% to Rs 593 crore on volumes, price rise

Britannia Q1 Results: Profit rises 14% to Rs 593 crore on volumes, price rise

0
Your Processes Are The Weakest Part Of Your AEO Strategy

Your Processes Are The Weakest Part Of Your AEO Strategy

0
OraSure expects Q3 revenue of .5M-.5M while delaying InteliQuick CT/NG FDA clearance beyond 2026 (NASDAQ:OSUR)

OraSure expects Q3 revenue of $29.5M-$32.5M while delaying InteliQuick CT/NG FDA clearance beyond 2026 (NASDAQ:OSUR)

0
Coinbase Lets UK Users Trade US Stocks While Wall Street Sleeps

Coinbase Lets UK Users Trade US Stocks While Wall Street Sleeps

0
When ‘Feelings Are Data’ To Navigate Clients’ Financial Planning Trade-Offs: Kitces & Carl 196

When ‘Feelings Are Data’ To Navigate Clients’ Financial Planning Trade-Offs: Kitces & Carl 196

0
GH Research Releases Q2 2026 Financial Results

GH Research Releases Q2 2026 Financial Results

0
Britannia Q1 Results: Profit rises 14% to Rs 593 crore on volumes, price rise

Britannia Q1 Results: Profit rises 14% to Rs 593 crore on volumes, price rise

August 6, 2026
OraSure expects Q3 revenue of .5M-.5M while delaying InteliQuick CT/NG FDA clearance beyond 2026 (NASDAQ:OSUR)

OraSure expects Q3 revenue of $29.5M-$32.5M while delaying InteliQuick CT/NG FDA clearance beyond 2026 (NASDAQ:OSUR)

August 6, 2026
GH Research Releases Q2 2026 Financial Results

GH Research Releases Q2 2026 Financial Results

August 6, 2026
Your Processes Are The Weakest Part Of Your AEO Strategy

Your Processes Are The Weakest Part Of Your AEO Strategy

August 6, 2026
Ooredoo teams up with Nvidia and Nokia to launch 1 GW AI platform in Indonesia

Ooredoo teams up with Nvidia and Nokia to launch 1 GW AI platform in Indonesia

August 6, 2026
Dell Technologies (DELL): Steht der Mega-Ausbruch kurz bevor?

Dell Technologies (DELL): Steht der Mega-Ausbruch kurz bevor?

August 6, 2026
theadvisertimes.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Britannia Q1 Results: Profit rises 14% to Rs 593 crore on volumes, price rise
  • OraSure expects Q3 revenue of $29.5M-$32.5M while delaying InteliQuick CT/NG FDA clearance beyond 2026 (NASDAQ:OSUR)
  • GH Research Releases Q2 2026 Financial Results
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • About Us
  • Contact Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.